Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Batten disease, the juvenile form of neuronal ceroid lipofuscinosis, is a prevalent neuron degenerative disorder of childhood. A 1.02-kb genomic deletion in the Batten disease gene CLN3 has been determined to be a common mutation. We developed a PCR method to screen for this deletion and tested 43 Batten disease probands. We found 36% (31/86) of Batten disease chromosomes did not carry the 1.02-kb deletion. Of the three heterozygotes for the 1.02-kb deletion, a novel G-to-A missense mutation at nucleotide 1020 of the CLN3 cDNA sequence was found on two of the non-1.02-kb deletion chromosomes. The missense mutation resulted in a substitution of glutamic acid (E) by lysine (K) at position 295 (E295 K). The E295 K mutation causes a change in predicted local protein conformation. This glutamic acid is a highly conserved acidic amino acid, being present in human, mouse, dog and yeast, which suggests it may play an important role in the function of the Batten disease protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unexpectedly, 14 of 113 literature-annotated disease mutations were either incorrect or incomplete (table S7) (35–39).”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [37]
Citations
Cites
Hall, N. A., Lake, B. D., Dewji, N. N., & Patrick, A. D. (1991) · Biochemical Journal · doi:10.1042/bj2750269 · Cited by 166
Kominami, E., Ezaki, J., Muno, D., Ishido, K., Ueno, T., & Wolfe, L. S. (1992) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123749 · Cited by 119
Fine structure of the lipid bodies in juvenile amaurotic idiocy
Zeman, W., & Donahue, S. (1963) · Acta Neuropathologica · doi:10.1007/bf00687063 · Cited by 107
Gardiner, M., Sandford, A. J., Deadman, M. E., Poulton, J., Cookson, W., Reeders, Jokiaho, I., Peltonen, L., Eiberg, H., & Julier, C. (1990) · Genomics · doi:10.1016/0888-7543(90)90297-8 · Cited by 99
Wisniewski, K. E., Kida, E., Patxot, O. F., & Connell, F. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420420 · Cited by 91
Self-citationA model for Batten disease protein CLN3: Functional implications from homology and mutations
Janes, R. W., Munroe, P. B., Mitchison, H. M., Gardiner, R. M., Mole, S., & Wallace, B. A. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01290-2 · Cited by 79
Ezaki, J., Wolfe, L. S., Higuti, T., Ishidoh, K., & Kominami, E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020733.x · Cited by 68
Mitchison, H. M., O'Rawe, A., Taschner, P. E. M., Sandkuijl, L. A., Santavuori, P., de Vos, N., Breuning, M. H., Mole, S., Gardiner, R. M., & Järvelä, I. E. (1995) · PubMed · Cited by 67
Genomic Structure and Complete Nucleotide Sequence of the Batten Disease Gene,CLN3
Mitchison, H. M., Munroe, P. B., O'Rawe, A., Taschner, P. E. M., de Vos, N., Kremmidiotis, G., Lensink, I. L., Munk, A. C., D'Arigo, K. L., Anderson, J. W., et al. (1997) · Genomics · doi:10.1006/geno.1996.4576 · Cited by 49
Regional mapping of the Batten disease locus (CLN3) to human chromosome 16p12.
Callen, D. F., Baker, E. G., Lane, S. A., Nancarrow, J. K., Thompson, A., Whitmore, S. A., MacLennan, D. H., Berger, R., Chérif, D., & Järvelä, I. E. (1991) · Europe PMC (PubMed Central) · Cited by 47
Cited by
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
Prevalence of lysosomal storage diseases in Portugal
Pinto, R., Caseiro, C., Lemos, M., Lopes, L., Fontes, A., Ribeiro, H., Pinto, E., Silva, E., Rocha, S., Marcão, A., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201044 · Cited by 341
Kousi, M., Lehesjoki, A.-E., & Mole, S. E. (2012) · Human Mutation · doi:10.1002/humu.21624 · Cited by 332
Fantini, J., & Yahi, N. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001602 · Cited by 173
Batten disease: evaluation of CLN3 mutations on protein localization and function
Haskell, R. E., Carr, C. J., Pearce, D. A., Bennett, M. J., & Davidson, B. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.735 · Cited by 104
1 Neuronal ceroid lipofuscinoses: Classification and diagnosis
Wisniewski, K. E., Kida, E., Golabek, A. A., Kaczmarski, W., Connell, F., & Zhong, N. A. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)45002-4 · Cited by 78
Self-citationThe CLN3 gene and protein: What we know
Mirza, M., Vainshtein, A., DiRonza, A., Chandrachud, U., Haslett, L. J., Palmieri, M., Storch, S., Groh, J., Dobzinski, N., Napolitano, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.859 · Cited by 74
Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis
Persaud‐Sawin, D. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2129 · Cited by 70
Persaud‐Sawin, D., McNamara, J. O., Rylova, S. N., VanDongen, A. M. J., & Boustany, R. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000136152.54638.95 · Cited by 74
Protein misfolding and degradation in genetic diseases
Bross, P., Corydon, T. J., Andresen, B. S., J�rgensen, M. M., Bolund, L., & Gregersen, N. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:3<186::aid-humu2>3.0.co;2-j · Cited by 236
Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis
Wisniewski, K. E., Zhong, N. A., Kaczmarski, W., Kaczmarski, A. L., Kida, E., Brown, W. T., Schwarz, K., Lazzarini, A. M., Rubin, A. J., Stenroos, E. S., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430118 · Cited by 55
Self-citationWisniewski, K. E., Kaczmarski, A. L., Kida, E., Connell, F., Kaczmarski, W., Michalewski, M. P., Moroziewicz, D. N., & Zhong, N. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2814 · Cited by 44
Self-citationTeixeira, C. A., Guimar�es, A., Bessa, C., Ferreira, M. J., Lopes, L., Pinto, E., Pinto, R., Boustany, R., Sá-Miranda, C., & Ribeiro, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1050-z · Cited by 41
Heterogeneity of late-infantile neuronal ceroid lipofuscinosis
Zhong, N., Moroziewicz, D. N., Ju, W., Jurkiewicz, A., Johnston, L., Wisniewski, K. E., & Brown, W. T. (2000) · Genetics in Medicine · doi:10.1097/00125817-200011000-00002 · Cited by 38
Self-citationTwo common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipoluscinosis
Zhong, N., Krystyna, Wisniewski, É., Hartikainen, J. M., Ju, W., Moroziewicz, D. N., McLendon, L., Brooks, S. S., & Brown, W. T. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb04291.x · Cited by 38
Self-citationBatten Disease: Four Genes and Still Counting
Mole, S. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0209 · Cited by 34
2 Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses
Kida, E., Golabek, A. A., & Wisniewski, K. E. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)45003-6 · Cited by 33
Self-citationLate Infantile Neuronal Ceroid Lipofuscinosis Is Due to Splicing Mutations in the CLN2 Gene
Hartikainen, J. M., Ju, W., Wisniewski, K. E., Moroziewicz, D. N., Kaczmarski, A. L., McLendon, L., Zhong, D., Suarez, C. T., Brown, W. T., & Zhong, N. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2853 · Cited by 32
Self-citationStudies of atypical JNCL suggest overlapping with other NCL forms
Wisniewski, K. E., Zhong, N., Kaczmarski, W., Kaczmarski, A. L., Sklower-Brooks, S., & Brown, W. T. (1998) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00188-4 · Cited by 30
Self-citationNeuronal Ceroid Lipofuscinoses and Possible Pathogenic Mechanism
Zhong, N. A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3057 · Cited by 28
Self-citationOetjen, S., Kuhl, D., & Hermey, G. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13744 · Cited by 26
Bauwens, M., Storch, S., Weisschuh, N., Groote, C. C., Rycke, R. M. D., Guillemyn, B., Jaegere, S. D., Coppieters, F., Coster, R. V., Leroy, B. P., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13673 · Cited by 20
Molecular Diagnosis of and Carrier Screening for the Neuronal Ceroid Lipofuscinoses
Zhong, N. A., Wisniewski, K. E., Ju, W., Moroziewicz, D. N., Jurkiewicz, A., McLendon, L., Jenkins, E. C., & Brown, W. T. (2000) · Genetic Testing · doi:10.1089/10906570050501452 · Cited by 16
Self-citationCLN -encoded proteins do not interact with each other
Zhong, N. A., Moroziewicz, D. N., Ju, W., Wisniewski, K. E., Jurkiewicz, A. M., & Brown, W. T. (2000) · Neurogenetics · doi:10.1007/pl00022978 · Cited by 16
Self-citation7 Molecular genetic testing for neuronal ceroid lipofuscinoses
Zhong, N. A. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)45008-5 · Cited by 15
Self-citationVillanova, M., Ceuterick, C., Dotti, M. T., Santorelli, F. M., Casali, C., Malandrini, A., Stefano, N. D., Lübke, U., Martin, J. J., Guazzi, G. C., et al. (1999) · Acta Neuropathologica · doi:10.1007/s004010051053 · Cited by 6
Gilani, N., Razmara, E., Özaslan, M., Abdulzahra, I. K., Arzhang, S., Tavasoli, A. R., & Garshasbi, M. (2021) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01655-9 · Cited by 6
CLN3 mediates chloride efflux from lysosomes
Wang, Y., Li, K., Chen, W., Chen, C., Yong, A. J. H., Zhang, X., Fontaine, M. T.-L., Jan, Y. N., & Jan, L. Y. (2026) · Neuron · doi:10.1016/j.neuron.2025.11.013 · Cited by 5
CLN3 disease process: missense point mutations and protein depletion in vitro
Golabek, A. A., Kida, E., Walus, M., Kaczmarski, W., Wujek, P., & Wisniewski, K. E. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0440 · Cited by 3
Self-citationPoyato, P., & del Socorro, M. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Molecular Interactions of Neuronal Ceroid Lipofuscinosis Protein CLN3
Uusi-Rauva, K. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS; BRAIN-RELATED SYMPTOMS AND THEIR TREATMENT
Åberg, L. E. (2001) · Työväentutkimus Vuosikirja · Cited by 2
Wang, G., He, Y., Hu, S., Liu, W., & Liu, G. (2009) · Journal of Animal and Feed Sciences · doi:10.22358/jafs/66368/2009
Learning and memory in theFMR1 knockout mouse
Fisch, G. S., Hao, H. K., Bakker, C., & Oostra, B. A. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990528)84:3<277::aid-ajmg22>3.0.co;2-w · Cited by 47
Self-citation
Metadata
- Authors
- Zhong, N., Wisniewski, K. E., Kaczmarski, A. L., Ju, W., Xu, W. M., Xu, W. W., Mclendon, L., Liu, B., Kaczmarski, W., Brooks, S. S., & Brown, W. T.
- Venue
- Human Genetics
- Published
- 1998-01-21
- Volume
- 102
- Issue
- 1
- Pages
- 57-62
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W2045986631
- Cited by
- 34
- References
- 16
- Citations by year
- 2026: 1 · 2021: 1 · 2019: 2 · 2016: 1 · 2012: 2
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- Batten disease, neuronal ceroid lipofuscinosis type 2, CLN3 gene, molecular screening, PCR-based mutation detection, heterozygotes, protein conformation, glutamate, lysine substitution, conserved residues, neurodegenerative diseases
- MeSH terms
- Amino Acid Sequence, Animals, Dogs, Genetic Testing, Humans, Lysine, Membrane Glycoproteins, Molecular Sequence Data, Neuronal Ceroid-Lipofuscinoses, Polymorphism, Genetic, Proteins, Polymerase Chain Reaction, Gene Deletion, Point Mutation, Alternative Splicing, Glutamic Acid, Molecular Chaperones, Amino Acid Substitution, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.